2-AA Labelled Glycans
-
Click to view our application note
Glucose Homopolymer (GHP) - a System Suitability and a Reference Standard for Glycan Analysis using Liquid Chromatography
HPLC Calibration Standard
-
2-AA labelled glucose homopolymer ladder
CAA-GHP-30
A4 Family Glycans
-
NA4 glycan (A4G4), 2-AA labelled
CAA-NA4-01
-
NGA4 glycan (A4), 2-AA labelled
CAA-NGA4-01
A3 Family Glycans
-
A3 glycan (A3G3S3), 2-AA labelled
CAA-A3-01
-
NA3 glycan (A3G3), 2-AA labelled
CAA-NA3-01
-
NGA3 glycan (A3), 2-AA labelled
CAA-NGA3-01
A2F Family Glycans
-
A2F glycan (FA2G2S2, G2FS2), 2-AA labelled
CAA-A2F-01
-
A1F glycan (FA2G2S1, G2FS1), 2-AA labelled
CAA-A1F-01
-
NA2F glycan (FA2G2, G2F), 2-AA labelled
CAA-NA2F-01
-
FA2G1 glycan (G1F), 2-AA labelled
CAA-FA2G1-01
-
NGA2F glycan (FA2, G0F), 2-AA labelled
CAA-NGA2F-01
-
FA2B glycan (G0B), 2-AA labelled
CAA-FA2B-01
2AA labelled FA2 (NGA2F) glycan containing bisecting N-acetylglucosamine
-
FA2BG1 glycan (G1B), 2-AA labelled
CAA-FA2BG1-01
2AA labelled FA2G1 glycan containing bisecting N-acetylglucosamine
A2 Family Glycans
-
A2 glycan (A2G2S2, G2S2), 2-AA labelled
CAA-A2-01
-
A1 glycan (A2G2S1, G2S1), 2-AA labelled
CAA-A1-01
-
NA2 glycan (A2G2, G2), 2-AA labelled
CAA-NA2-01
-
A2G1 glycan (G1), 2AA labelled
CAA-A2G1-01
-
NGA2 glycan (A2, G0), 2-AA labelled
CAA-NGA2-01
Oligomannose Glycans
-
Man-9 glycan, 2-AA labelled
CAA-MAN9-01
-
Man-8 glycan, 2-AA labelled
CAA-MAN8-01
-
Man-7 glycan, 2-AA labelled
CAA-MAN7-01
-
Man-6 glycan, 2-AA labelled
CAA-MAN6-01
-
Man-5 glycan, 2-AA labelled
CAA-MAN5-01
-
M3N2 (Man-3) glycan, 2-AA labelled
CAA-M3N2-01
Hybrid Family Glycans
-
Hybrid glycan (Man5BA1), 2-AA labelled
CAA-HYBRID-01 *Product discontinued - documents for reference
Other
-
Gal alpha 1-3 Gal beta 1-4 GlcNAc, 2-AA labelled
CAA-AlphaGal-01
Document Library
- Application Note: Quantitative Sialic Acid Analysis
- Glycan Certificate of Stability
- Glycan Analysis Products Flowchart
- Sialylation Guide I: Neu5Ac and Neu5Gc Quantitation
- Sialylation Guide II: Highly Sialylated Glycoproteins
- Reducing risk in biopharmaceutical production by controlling glycosylation
- Biopharmaceutical sialylation
- How to improve safety and efficacy profiles of therapeutic antibodies
- Demonstrating comparability of antibody glycosylation during biomanufacturing
- Article on fluorescent labelling methods for glycan analysis
- Sending samples to Ludger for glycan analysis